Methods for assessing insulin resistance in gestational diabetes mellitus
https://doi.org/10.21886/2219-8075-2022-13-1-5-12
Abstract
Among all endocrine diseases complicating pregnancy, gestational diabetes mellitus (GSD) is the most common. Th is violation of carbohydrate metabolism poses a serious threat to the health of the mother and fetus, associated with a high risk of perinatal complications. At the same time, the eff ective achievement of normoglycemia in a woman suff ering from GSD can signifi cantly improve the prognosis. Th e choice of GSD therapy depends on a number of factors and is decided individually in each case. One of the factors determining the eff ectiveness of non-drug therapy and the need for pharmacological correction may be related to the pathophysiological aspects of the formation of hyperglycemia during pregnancy. Currently, they talk about the heterogeneity of GSD and distinguish its various subtypes depending on the predominance of pancreatic beta-cell dysfunction, insulin resistance (IR) or a combination of these factors in the pathogenesis. Since the prevailing criterion for the verifi cation of GSD subtypes is the presence and severity of IR, various methods of its verifi cation are considered in this review. It is shown that the currently available methods for detecting IR have a number of disadvantages, consisting both in the complexity and complexity of implementation (hyperinsulinemic euglycemic clamp) and in the absence of clear reference intervals (mathematical models). It is necessary to continue research aimed at studying IR methods for the subsequent identifi cation of GSD subtypes.
About the Authors
N. I. VolkovaRussian Federation
Natalya I. Volkova - Dr. Sci. (Med.), Professor, ViceСhancellor on Scientifi c Research, head of Department of internal diseases №3.
Rostovon-Don
Competing Interests:
Authors declares no confl ict of interest
I. Yu. Davidenko
Russian Federation
Ilya Y. Davidenko - Cand. Sci. (Med.), associate professor of Department of internal medicine №3.
Rostov-on-Don
Competing Interests:
Authors declares no confl ict of interest
Yu. A. Sorokina
Russian Federation
Yuliya А. Sorokina - MD, researcher.
Rostov-on-Don
Competing Interests:
Authors declares no confl ict of interest
Yu. S. Degtyareva
Russian Federation
Yuliya S. Degtyareva - postgraduate student of Department of internal diseases №3.
Rostov-on-Don
Competing Interests:
Authors declares no confl ict of interest
E. M. London
Russian Federation
Evgeny M. London – MD, head of the therapeutic department.
Rostovon-Don
Competing Interests:
Authors declares no confl ict of interest
References
1. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. DOI: 10.1038/s41572-019-0098-8
2. Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. Th e Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018;19(11):3342. DOI: 10.3390/ijms19113342
3. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev. 2003;19(4):259-70. DOI: 10.1002/dmrr.390
4. Ashcroft FM, Rohm M, Clark A, Brereton MF. Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells? Cell Metab. 2017;26(1):17-23. DOI: 10.1016/j.cmet.2017.05.014
5. Volkova N.I., Davidenko I.Yu., Degtyareva Yu.S. Gestational diabetes mellitus. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021;9:174-179 (In Russ.). DOI: 10.18565/aig.2021.9.174-179
6. Powe CE, Allard C, Battista MC, Doyon M, Bouchard L, et al. Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus. Diabetes Care. 2016;39(6):1052-5. DOI: 10.2337/dc15-2672
7. Liu Y, Hou W, Meng X, Zhao W, Pan J, et al. Heterogeneity of insulin resistance and beta cell dysfunction in gestational diabetes mellitus: a prospective cohort study of perinatal outcomes. J Transl Med. 2018;16(1):289. DOI: 10.1186/s12967-018-1666-5
8. Feghali M, Atlass J, Ribar E, Caritis S, Simhan H, Scifres C. 82: Subtypes of gestational diabetes mellitus based on mechanisms of hyperglycemia. American Journal of Obstetrics and Gynecology. 2019;220(1):S66. DOI: 10.1016/j.ajog.2018.11.091
9. Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, et al. Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia. 2019;62(11):2118-2128. DOI: 10.1007/s00125-019-4961-7
10. Mayorov A.Y., Urbanova K.A., Galstyan G.R. Methods for guantifi cative assessment of insulin resistance. Obesity and metabolism. 2009;6(2):19-23. (In Russ.). DOI: 10.14341/2071-8713-5313
11. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607. DOI: 10.2337/diab.37.12.1595
12. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, et al. Insulin sensitivity index, acute insulin response, and glucose eff ectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fi tness, and life-style factors. J Clin Invest. 1996;98(5):1195-209. DOI: 10.1172/JCI118903
13. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. Eff ect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia. 1994;37(10):1025-35. DOI: 10.1007/BF00400466
14. Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015;19(1):160-4. DOI: 10.4103/2230-8210.146874
15. 15 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-23. DOI: 10.1152/ajpendo.1979.237.3.E214
16. 16 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. DOI: 10.1007/BF00280883
17. 17 Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-95. DOI: 10.2337/diacare.27.6.1487
18. 18 Chen H, Sullivan G, Yue LQ, Katz A, Quon MJ. QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am J Physiol Endocrinol Metab. 2003;284(4):E804-12. DOI: 10.1152/ ajpendo.00330.2002
19. 19 Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462-70. DOI: 10.2337/diacare.22.9.1462
20. 20 McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24(3):460-4. DOI: 10.2337/diacare.24.3.460
21. 21 Belfi ore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab. 1998;63(2):134-41. DOI: 10.1006/mgme.1997.2658
22. 22 Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract. 1990;10:167-75. DOI: 10.1016/0168-8227(90)90040-z
23. 23 Stumvoll M, Gerich J. Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes. Clin Lab Med. 2001;21(1):31-51. PMID: 11321936
Review
For citations:
Volkova N.I., Davidenko I.Yu., Sorokina Yu.A., Degtyareva Yu.S., London E.M. Methods for assessing insulin resistance in gestational diabetes mellitus. Medical Herald of the South of Russia. 2022;13(1):5-12. (In Russ.) https://doi.org/10.21886/2219-8075-2022-13-1-5-12